Family Medicine · Anderson, IN
NPI
1487676706
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1601 Medical Arts Blvd, Suite 100
Anderson, IN, 46011
Phone (765) 298-5700
Groups this clinician bills Medicare through
Medicare paid, 2024
$84K
1,570 services
Medicare patients, 2024
292
Average age 76
Drug cost, 2024
$2.6M
15,933 prescriptions
Company payments, 2025
$2,786
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd A Rhoades was code 99213 (office e&m - established), 403 times for 238 patients. In total Todd A Rhoades billed 1,570 services in 44 codes, and Medicare paid $84K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 403 | 238 | $51.80 | $21K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 191 | 191 | $120.33 | $23K |
| G0008 Administration of influenza virus vaccine | Office | 107 | 98 | $30.10 | $3,221 |
| 90662 Vaccine Product | Office | 91 | 91 | $80.92 | $7,364 |
| 99214 Office E&M - Established | Office | 81 | 76 | $69.06 | $5,594 |
| 81003 Clinical Chemistry | Office | 58 | 56 | $2.20 | $128 |
| 99212 Office E&M - Established | Office | 56 | 55 | $32.36 | $1,812 |
| 96372 Injection Administration | Office | 49 | 13 | $7.76 | $380 |
| 90480 Vaccine Administration | Office | 44 | 42 | $40.13 | $1,766 |
| 91322 Vaccine Product | Office | 44 | 42 | $156.32 | $6,878 |
| 83036 Blood Count | Office | 40 | 33 | $9.52 | $381 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 20 | 20 | $68.88 | $1,378 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 17 | 17 | $153.54 | $2,610 |
| 90694 Vaccine Product | Office | 16 | 16 | $75.81 | $1,213 |
| 90677 Vaccine Product | Office | 14 | 14 | $290.11 | $4,062 |
By year: 2022 $124K for 6,699 services; 2023 $88K for 1,491 services; 2024 $84K for 1,570 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 58 | 56 | $2.20 | $128 |
| 83036 Blood Count | 40 | 33 | $9.52 | $381 |
| 87428 Infectious Agent Detection by DNA/RNA | 20 | 20 | $68.88 | $1,378 |
Medicare prescription drug claims, 2024
In 2024, the drug Todd A Rhoades prescribed most often to Medicare patients was Atorvastatin Calcium, with 982 prescriptions and refills. In total Todd A Rhoades wrote 15,933 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 982 | 2,777 | 262 | $10K |
| Levothyroxine Sodium Generic | 608 | 1,687 | 161 | $5,280 |
| Omeprazole Generic | 507 | 1,413 | 154 | $7,580 |
| Amlodipine Besylate Generic | 465 | 1,348 | 131 | $3,703 |
| Losartan Potassium Generic | 464 | 1,317 | 129 | $5,540 |
| Rosuvastatin Calcium Generic | 413 | 1,233 | 128 | $6,228 |
| Jardiance Empagliflozin | 412 | 780 | 97 | $448K |
| Gabapentin Generic | 408 | 961 | 141 | $8,257 |
| Metoprolol Succinate Generic | 349 | 982 | 98 | $5,443 |
| Metformin Hcl Generic | 343 | 945 | 106 | $2,245 |
| Lisinopril Generic | 342 | 963 | 96 | $2,389 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 243 | 324 | 98 | $6,494 |
| Pravastatin Sodium Generic | 243 | 699 | 66 | $2,279 |
| Fluticasone Propionate Generic | 239 | 455 | 98 | $3,727 |
| Tamsulosin Hcl Generic | 220 | 629 | 64 | $4,431 |
Brand drugs: 2,891 claims; generic drugs: 12,890 claims; opioid claims: 250.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Todd A Rhoades $2,786 ($2,786 in general payments such as food, travel and fees) from 20 companies. The largest payer was Novo Nordisk Inc with $426.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 23 | $426 |
| Abbvie Inc. ABBV | 27 | $408 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 17 | $340 |
| Pfizer Inc. PFE | 17 | $239 |
| Amgen Inc. AMGN | 16 | $189 |
| Lilly USA, LLC LLY | 10 | $173 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $167 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 9 | $165 |
| Axsome Therapeutics, Inc. AXSM | 6 | $124 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $115 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.